Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2010Expert Review of Molecular Diagnostics

Xpert®MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?

View Full Paper
Ask AI
Bookmark
Share

Authors

ARAnnelies Van RieLPLiesl Page‐ShippLSLesley Scott

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rie et al. (2010) studied this question.

synapsesocial.com/papers/6a8ae32ac12eaf65c8b1ec4dhttps://doi.org/10.1586/erm.10.67
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Lysis Filtration and an Automated Blood Culture System (BACTEC) for Detection, Quantification, and Identification of Odontogenic Bacteremia in Children2002 · 78 citations
  2. 2Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa2008 · 395 citations
  3. 3Rapid Detection of <i>Mycobacterium tuberculosis</i> and Rifampin Resistance by Use of On-Demand, Near-Patient Technology2009 · 932 citations
  4. 4Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay2010 · 494 citations
  5. 5The Impact of HIV Infection and CD4 Cell Count on the Performance of an Interferon Gamma Release Assay in Patients with Pulmonary Tuberculosis2009 · 110 citations